111 related articles for article (PubMed ID: 32272507)
21. α
Cheung KW; Wu T; Ho SF; Wong YC; Liu L; Wang H; Chen Z
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386290
[TBL] [Abstract][Full Text] [Related]
22. Safety and Immunological Evaluation of Interleukin-21 Plus Anti-α4β7 mAb Combination Therapy in Rhesus Macaques.
Pino M; Uppada SB; Pandey K; King C; Nguyen K; Shim I; Rogers K; Villinger F; Paiardini M; Byrareddy SN
Front Immunol; 2020; 11():1275. PubMed ID: 32765488
[TBL] [Abstract][Full Text] [Related]
23. Vedolizumab-mediated integrin α4β7 blockade does not control HIV-1SF162 rebound after combination antiretroviral therapy interruption in humanized mice.
Ling L; Wu T; To KKW; Cheung KW; Lui KOL; Niu M; Lam KS; Wang CC; Li J; Wang H; Yuen KY; Chen Z
AIDS; 2019 Mar; 33(4):F1-F12. PubMed ID: 30829743
[TBL] [Abstract][Full Text] [Related]
24. An open-label phase 1 clinical trial of the anti-α
Sneller MC; Clarridge KE; Seamon C; Shi V; Zorawski MD; Justement JS; Blazkova J; Huiting ED; Proschan MA; Mora JR; Shetzline M; Moir S; Lane HC; Chun TW; Fauci AS
Sci Transl Med; 2019 Sep; 11(509):. PubMed ID: 31488581
[TBL] [Abstract][Full Text] [Related]
25. Frequency of Effector Memory Cells Expressing Integrin α
Kasarpalkar NJ; Bhowmick S; Patel V; Savardekar L; Agrawal S; Shastri J; Bhor VM
Front Immunol; 2021; 12():651122. PubMed ID: 33828560
[TBL] [Abstract][Full Text] [Related]
26. The Role of Integrin α
Arthos J; Cicala C; Nawaz F; Byrareddy SN; Villinger F; Santangelo PJ; Ansari AA; Fauci AS
Curr HIV/AIDS Rep; 2018 Apr; 15(2):127-135. PubMed ID: 29478152
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility.
McKinnon LR; Nyanga B; Chege D; Izulla P; Kimani M; Huibner S; Gelmon L; Block KE; Cicala C; Anzala AO; Arthos J; Kimani J; Kaul R
J Immunol; 2011 Dec; 187(11):6032-42. PubMed ID: 22048765
[TBL] [Abstract][Full Text] [Related]
28. Early infection HIV-1 envelope V1-V2 genotypes do not enhance binding or replication in cells expressing high levels of α4β7 integrin.
Etemad B; Gonzalez OA; McDonough S; Pena-Cruz V; Sagar M
J Acquir Immune Defic Syndr; 2013 Nov; 64(3):249-53. PubMed ID: 23797693
[TBL] [Abstract][Full Text] [Related]
29. Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions.
Wibmer CK; Richardson SI; Yolitz J; Cicala C; Arthos J; Moore PL; Morris L
Nat Commun; 2018 Oct; 9(1):4489. PubMed ID: 30367034
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the integrin α4β7 expression pattern of memory T cell subsets in HIV infection and ulcerative colitis.
Wittner M; Schlicker V; Libera J; Bockmann JH; Horvatits T; Seiz O; Kummer S; Manthey CF; Hüfner A; Kantowski M; Rösch T; Degen O; Huber S; Eberhard JM; Schulze Zur Wiesch J
PLoS One; 2019; 14(7):e0220008. PubMed ID: 31356607
[TBL] [Abstract][Full Text] [Related]
31. IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa.
Cimbro R; Vassena L; Arthos J; Cicala C; Kehrl JH; Park C; Sereti I; Lederman MM; Fauci AS; Lusso P
Blood; 2012 Sep; 120(13):2610-9. PubMed ID: 22896005
[TBL] [Abstract][Full Text] [Related]
32. Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates.
Fabrizio C; Bavaro DF; Scudeller L; Lepore L; Balena F; Lagioia A; Angarano G; Monno L; Saracino A
Virology; 2019 Sep; 535():266-271. PubMed ID: 31357165
[TBL] [Abstract][Full Text] [Related]
33. Preferential and persistent depletion of CCR5+ T-helper lymphocytes with nonlymphoid homing potential despite early treatment of primary HIV infection.
Krzysiek R; Rudent A; Bouchet-Delbos L; Foussat A; Boutillon C; Portier A; Ingrand D; Sereni D; Galanaud P; Grangeot-Keros L; Emilie D;
Blood; 2001 Nov; 98(10):3169-71. PubMed ID: 11698309
[TBL] [Abstract][Full Text] [Related]
34. Expression of alpha4beta7 and E-selectin ligand by circulating memory B cells: implications for targeted trafficking to mucosal and systemic sites.
Rott LS; Briskin MJ; Butcher EC
J Leukoc Biol; 2000 Dec; 68(6):807-14. PubMed ID: 11129647
[TBL] [Abstract][Full Text] [Related]
35. The association of α4β7 expression with HIV acquisition and disease progression in people who inject drugs and men who have sex with men: Case control studies.
Martin AR; Patel EU; Kirby C; Astemborski J; Kirk GD; Mehta SH; Marshall K; Janes H; Clayton A; Corey L; Hammer SM; Sobieszczyk ME; Arthos J; Cicala C; Redd AD; Quinn TC
EBioMedicine; 2020 Dec; 62():103102. PubMed ID: 33166790
[TBL] [Abstract][Full Text] [Related]
36. Human Blood-Circulating Basophils Capture HIV-1 and Mediate Viral trans-Infection of CD4+ T Cells.
Jiang AP; Jiang JF; Guo MG; Jin YM; Li YY; Wang JH
J Virol; 2015 Aug; 89(15):8050-62. PubMed ID: 26018157
[TBL] [Abstract][Full Text] [Related]
37. A high mucosal blocking score is associated with HIV protection.
Girard A; Rallón N; Benito JM; Jospin F; Rodriguez C; Chanut B; Benjelloun F; Del Romero J; Verrier B; Lucht F; Pin JJ; Genin C; Biasin M; Clerici M; Paul S
AIDS; 2019 Mar; 33(3):411-423. PubMed ID: 30703069
[TBL] [Abstract][Full Text] [Related]
38. Worldwide Genetic Features of HIV-1 Env α4β7 Binding Motif: The Local Dissemination Impact of the LDI Tripeptide.
Hait SH; Soares EA; Sprinz E; Arthos J; Machado ES; Soares MA
J Acquir Immune Defic Syndr; 2015 Dec; 70(5):463-71. PubMed ID: 26569174
[TBL] [Abstract][Full Text] [Related]
39. The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression.
Jelicic K; Cimbro R; Nawaz F; Huang da W; Zheng X; Yang J; Lempicki RA; Pascuccio M; Van Ryk D; Schwing C; Hiatt J; Okwara N; Wei D; Roby G; David A; Hwang IY; Kehrl JH; Arthos J; Cicala C; Fauci AS
Nat Immunol; 2013 Dec; 14(12):1256-65. PubMed ID: 24162774
[TBL] [Abstract][Full Text] [Related]
40. Homing commitment of lymphocytes activated in the human gastric and intestinal mucosa.
Quiding-Järbrink M; Ahlstedt I; Lindholm C; Johansson EL; Lönroth H
Gut; 2001 Oct; 49(4):519-25. PubMed ID: 11559649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
